Dataset from A Phase 1, Open Label, Dose Escalation Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Subjects With Relapsed or Refractory Solid Tumors
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009306
下载链接
链接失效反馈官方服务：
资源简介：
Phase 1, open-labeled, dose escalation safety and tolerability study for the treatment of
subjects with relapsed or refractory solid tumors.
创建时间：
2025-07-07
